Iws1 Inhibitors
Iws1 inhibitors belong to a class of chemical compounds that have been designed to selectively target and interfere with the activity of the Iws1 gene or its encoded protein product. Iws1, also known as Interacts with Spt6 1, is a less extensively studied gene or protein compared to some well-characterized counterparts in molecular biology. These inhibitors are developed with the objective of modulating the function of Iws1, which may be involved in various biological processes, including transcriptional regulation, RNA processing, or other molecular interactions within cells.
The primary mechanism of action for Iws1 inhibitors generally involves their interaction with the Iws1 protein or its associated molecules, resulting in the disruption of its normal function. By inhibiting Iws1, these compounds have the to impact cellular processes under its control, although the specific functions of Iws1 are still being explored by researchers. Scientists studying Iws1 inhibitors aim to elucidate the specific roles and functions of Iws1 in cellular biology, contributing to our understanding of its significance within cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylase, potentially altering chromatin and affecting transcription where IWS1 is involved. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine can change chromatin structure and potentially downregulate IWS1 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin binds to DNA and inhibits RNA polymerase, which could reduce the transcription of IWS1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
As an intercalator, Actinomycin D inhibits RNA polymerase and may decrease IWS1 mRNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide has been shown to inhibit transcriptional activity and may affect IWS1 expression as part of its broader effects. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-Amanitin strongly inhibits RNA polymerase II, possibly reducing IWS1 expression through transcriptional repression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB is a transcription inhibitor that could nonspecifically reduce the levels of IWS1 mRNA. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits CDK9, a component of P-TEFb involved in transcription elongation, which could indirectly affect IWS1 expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Rocaglamide inhibits eukaryotic translation and could thereby lower global protein levels, including IWS1. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin is an adenosine analog that disrupts RNA synthesis, potentially leading to reduced expression of IWS1. | ||||||